Mario Pupo-Meriño

Mr. Mario Pupo-Meriño

Universidad de las Ciencias Informáticas
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2019 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
CGCesar Raul Garcia-Jacas
Cesar Raul Garcia-Jacas
Yovani Marrero-PonceYovani Marrero-Ponce
Yovani Marrero-Ponce
Fernando Cortes-GuzmanFernando Cortes-Guzman
Fernando Cortes-Guzman
JSJosé Suárez-Lezcano
José Suárez-Lezcano
FMFelix Martinez-Rios
Felix Martinez-Rios
KMKarina Martinez-Mayorga
Karina Martinez-Mayorga

25 February 2016 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
CGCesar Raul Garcia-Jacas
Cesar Raul Garcia-Jacas
Ernesto Contreras-TorresErnesto Contreras-Torres
Ernesto Contreras-Torres
Yovani Marrero-PonceYovani Marrero-Ponce
Yovani Marrero-Ponce
Mario Pupo-MeriñoMario Pupo-Meriño
Mario Pupo-Meriño
SBStephen J. Barigye
Stephen J. Barigye
LCLisset Cabrera-Leyva
Lisset Cabrera-Leyva
Recently, novel 3D alignment-free molecular descriptors (also known as QuBiLS-MIDAS) based on two-linear, three-linear and four-linear algebraic forms have been introduced. These descriptors codify chemical information for relations between two, three and four atoms by using several (dis-)similarity metrics and multi-metrics. Several studies aimed at assessing the quality of these novel descriptors have been performed. However, a deeper analysis of their performance is necessary. Therefore, in the present manuscript an assessment and statistical validation of the performance of these novel descriptors in QSAR studies is performed. To this end, eight molecular datasets (angiotensin converting enzyme, acetylcholinesterase inhibitors, benzodiazepine receptor, cyclooxygenase-2 inhibitors, dihydrofolate reductase inhibitors, glycogen phosphorylase b, thermolysin inhibitors, thrombin inhibitors) widely used as benchmarks in the evaluation of several procedures are utilized. Three to nine variable QSAR models based on Multiple Linear Regression are built for each chemical dataset according to the original division into training/test sets. Comparisons with respect to leave-one-out cross-validation correlation coefficients $$\left( {Q_{loo}^{2} } \right)$$ Q l o o 2 reveal that the models based on QuBiLS-MIDAS indices possess superior predictive ability in 7 of the 8 datasets analyzed, outperforming methodologies based on similar or more complex techniques such as: Partial Least Square, Neural Networks, Support Vector Machine and others. On the other hand, superior external correlation coefficients $$\left( {Q_{ext}^{2} } \right)$$ Q e x t 2 are attained in 6 of the 8 test sets considered, confirming the good predictive power of the obtained models. For the $$Q_{ext}^{2}$$ Q e x t 2 values non-parametric statistic tests were performed, which demonstrated that the models based on QuBiLS-MIDAS indices have the best global performance and yield significantly better predictions in 11 of the 12 QSAR procedures used in the comparison. Lastly, a study concerning to the performance of the indices according to several conformer generation methods was performed. This demonstrated that the quality of predictions of the QSAR models based on QuBiLS-MIDAS indices depend on 3D structure generation method considered, although in this preliminary study the results achieved do not present significant statistical differences among them. As conclusions it can be stated that the QuBiLS-MIDAS indices are suitable for extracting structural information of the molecules and thus, constitute a promissory alternative to build models that contribute to the prediction of pharmacokinetic, pharmacodynamics and toxicological properties on novel compounds. Graphical abstract Comparative graphical representation of the performance of the novel QuBiLS-MIDAS 3D-MDs with respect to other methodologies in QSAR modeling of eight chemical datasets

13 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MFMagilé C Fonseca
Magilé C Fonseca
Mario Pupo-MeriñoMario Pupo-Meriño
Mario Pupo-Meriño
Luis A. García-GonzálezLuis A. García-González
Luis A. García-González
SRSonia Resik
Sonia Resik
LHLai Heng Hung
Lai Heng Hung
LSLuis Sarmiento
Luis Sarmiento
Coxsackievirus A24 variant (CVA24v) is a major causative agent of acute hemorrhagic conjunctivitis outbreaks worldwide, yet the evolutionary and transmission dynamics of the virus remain unclear. To address this, we analyzed and compared the 3C and partial VP1 gene regions of CVA24v isolates obtained from five outbreaks in Cuba between 1986 and 2009 and strains isolated worldwide. Here we show that Cuban strains were homologous to those isolated in Africa, the Americas and Asia during the same time period. Two genotypes of CVA24v (GIII and GIV) were repeatedly introduced into Cuba and they arose about two years before the epidemic was detected. The two genotypes co-evolved with a population size that is stable over time. However, nucleotide substitution rates peaked during pandemics with 4.39 × 10−3 and 5.80 × 10−3 substitutions per site per year for the 3C and VP1 region, respectively. The phylogeographic analysis identified 25 and 19 viral transmission routes based on 3C and VP1 regions, respectively. Pandemic viruses usually originated in Asia, and both China and Brazil were the major hub for the global dispersal of the virus. Together, these data provide novel insight into the epidemiological dynamics of this virus and possibly other pandemic viruses.

30 November 2009 in Toxicon
Verified
Journal Article
Closed access
GCGloria Celedón
Gloria Celedón
GGGustavo González
Gustavo González
ELEduardo Lissi
Eduardo Lissi
TCTania Cerda
Tania Cerda
DMDiana Martinez
Diana Martinez
CACarlos Alvarez
Carlos Alvarez

Verified
Journal Article
Open access
PDF file
CKCarolin Kling
Carolin Kling
ASAnja Sommer
Anja Sommer
YAYasser Almeida-Hernandez
Yasser Almeida-Hernandez
AAArmando Alexei Rodríguez Alfonso
Armando Alexei Rodríguez Alfonso
JPJulio A. Perez-Erviti
Julio A. Perez-Erviti
KEKatharina Ernst
Katharina Ernst
Whooping cough is a severe childhood disease, caused by the bacterium Bordetella pertussis, which releases pertussis toxin (PT) as a major virulence factor. Previously, we identified the human antimicrobial peptides α-defensin-1 and -5 as inhibitors of PT and demonstrated their capacity to inhibit the activity of the PT enzyme subunit PTS1. Here, the underlying mechanism of toxin inhibition was investigated in more detail, which is essential for developing the therapeutic potential of these peptides. Flow cytometry and immunocytochemistry revealed that α-defensin-5 strongly reduced PT binding to, and uptake into cells, whereas α-defensin-1 caused only a mild reduction. Conversely, α-defensin-1, but not α-defensin-5 was taken up into different cell lines and interacted with PTS1 inside cells, based on proximity ligation assay. In-silico modeling revealed specific interaction interfaces for α-defensin-1 with PTS1 and vice versa, unlike α-defensin-5. Dot blot experiments showed that α-defensin-1 binds to PTS1 and even stronger to its substrate protein Gαi in vitro. NADase activity of PTS1 in vitro was not inhibited by α-defensin-1 in the absence of Gαi. Taken together, these results suggest that α-defensin-1 inhibits PT mainly by inhibiting enzyme activity of PTS1, whereas α-defensin-5 mainly inhibits cellular uptake of PT. These findings will pave the way for optimization of α-defensins as novel therapeutics against whooping cough.

5 March 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
MFMagilé C Fonseca
Magilé C Fonseca
Mario Pupo-MeriñoMario Pupo-Meriño
Mario Pupo-Meriño
Luis A. García-GonzálezLuis A. García-González
Luis A. García-González
MMMayra Muné
Mayra Muné
SRSonia Resik
Sonia Resik
LSLuis Sarmiento
Luis Sarmiento
Coxsackievirus A24 variant (CVA24v), the main causative agent of acute hemorrhagic conjunctivitis (AHC), can be isolated from both the eyes and lower alimentary tract. However, the molecular features of CVA24v in feces is not well-documented. In this study, we compared the VP1 and 3C sequences of CVA24v strains isolated from feces during AHC epidemics in Cuba in 1997, 2003, and 2008–2009 with those obtained from conjunctival swabs during the same epidemic period. The sequence analyses of the 3C and VP1 region of stool isolates from the three epidemics showed a high degree of nucleotide identity (ranging from 97.3–100%) to the corresponding conjunctival isolates. The phylogenetic analysis showed that fecal CVA24v isolates from the 1997 and 2003 Cuban outbreaks formed a clade with CVA24v strains isolated from conjunctival swabs in Cuba and other countries during the same period. There were three amino acid changes (3C region) and one amino acid change (VP1 region) in seven CVA24v strains isolated sequentially over 20 days from fecal samples of one patient, suggesting viral replication in the intestine. Despite these substitutions, the virus from the conjunctival swab and fecal samples were genetically very similar. Therefore, fecal samples should be considered as a reliable alternative sample type for the routine molecular diagnosis and molecular epidemiology of CVA24v, also during outbreaks of AHC.